Skip to main content
Equibles

Man Group plc

Position in VCEL — Vericel Corp

CIK 1637460 LONDON, X0
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,998,314
+$757,899 QoQ
Shares Held
67,393
-3.2% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 317 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 74% Shared 0% None 26%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. VCEL ranks #48 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in VCEL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,998,314 67,393
2026-03-31 $2,240,415 69,643
2025-12-31 $892,651 24,789
2024-09-30 $566,867 13,417
2024-06-30 $3,442,468 75,032
2024-03-31 $5,317,952 102,229
2023-12-31 $5,530,233 155,300
2023-09-30 $3,767,648 112,400
2023-06-30 $1,085,773 28,900
2023-03-31 $1,460,136 49,800
2020-12-31 $623,776 20,200